Unraveling dynamic activities of autocrine pathways that control drug-response transcriptome networks

• Published in: Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing p. 251
• Main Authors: Tamada, Yoshinori, Araki, Hiromitsu, Imoto, Seiya, Nagasaki, Masao, Doi, Atsushi, Nakanishi, Yukiko, Tomiyasu, Yuki, Yasuda, Kaori, Dunmore, Ben, Sanders, Deborah, Humphreys, Sally, Print, Cristin, Charnock-Jones, D Stephen, Tashiro, Kousuke, Kuhara, Satoru, Miyano, Satoru
• Format: Journal Article
• Language: English
• Published: United States 2009
• Subjects: Autocrine Communication - drug effects; Autocrine Communication - genetics; Bayes Theorem; Biometry; Cells, Cultured; Databases, Factual; Databases, Genetic; Fenofibrate - pharmacology; Gene Expression Profiling - statistics & numerical data; Gene Regulatory Networks; Humans; Hypolipidemic Agents - pharmacology; Models, Biological; Oligonucleotide Array Sequence Analysis - statistics & numerical data; Pharmacogenetics - statistics & numerical data; PPAR alpha - agonists; PPAR alpha - genetics; Protein Interaction Mapping - statistics & numerical data
• ISSN: 2335-6936

Some drugs affect secretion of secreted proteins (e.g. cytokines) released from target cells, but it remains unclear whether these proteins act in an autocrine manner and directly effect the cells on which the drugs act. In this study, we propose a computational method for testing a biological hypothesis: there exist autocrine signaling pathways that are dynamically regulated by drug response transcriptome networks and control them simultaneously. If such pathways are identified, they could be useful for revealing drug mode-of-action and identifying novel drug targets. By the node-set separation method proposed, dynamic structural changes can be embedded in transcriptome networks that enable us to find master-regulator genes or critical paths at each observed time. We then combine the protein-protein interaction network with the estimated dynamic transcriptome network to discover drug-affected autocrine pathways if they exist. The statistical significance (p-values) of the pathways are evaluated by the meta-analysis technique. The dynamics of the interactions between the transcriptome networks and the signaling pathways will be shown in this framework. We illustrate our strategy by an application using anti-hyperlipidemia drug, Fenofibrate. From over one million protein-protein interaction pathways, we extracted significant 23 autocrine-like pathways with the Bonferroni correction, including VEGF-NRP1-GIPC1-PRKCA-PPARalpha, that is one of the most significant ones and contains PPARalpha, a target of Fenofibrate.